Hepatitis C Virus NS5A Physically Associates with p53 and Regulates p21/waf1 Gene Expression in a p53-Dependent Manner
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
We have previously demonstrated that hepatitis C virus (HCV) NS5A protein promotes cell growth and transcriptionally regulates the p21/waf1 promoter, a downstream effector gene of p53. In this study, we investigated the molecular mechanism of NS5A-mediated transcriptional repression of p21/waf1. We observed that transcriptional repression of the p21/waf1 gene by NS5A is p53 dependent by using p53 wild-type (+/+) and null (−/−) cells. Interestingly, p53-mediated transcriptional activation from a synthetic promoter containing multiple p53 binding sites (PG13-LUC) was abrogated following expression of HCV NS5A. Additional studies using pull-down experiments, in vivo coimmunoprecipitation, and mammalian two-hybrid assays demonstrated that NS5A physically associates with p53. Confocal microscopy revealed sequestration of p53 in the perinuclear membrane and colocalization with NS5A in transfected HepG2 and Saos-2 cells. Together these results suggest that an association of NS5A and p53 allows transcriptional modulation of the p21/waf1 gene and may contribute to HCV-mediated pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321 · cited 8×
“Induction of p21/waf1 is a common mechanism of growth arrest in different physiological situations (6).”
BackgroundInfluentialp53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
Choo, Q.-L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W., & Houghton, M. (1989) · Science · doi:10.1126/science.2523562 · Cited by 6,875
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113 · cited 1×
“The adenovirus E1B 55-kDa protein, the human MDM2 protein, and hepatitis B virus X protein are known to bind to the transactivation domain of p53 for inhibition of its functional activity (19, 23, 25, 43).”
BackgroundKo, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., & Vogelstein, B. (1993) · Nature · doi:10.1038/362857a0 · Cited by 1,451
Hepatitis C virus infection is associated with the development of hepatocellular carcinoma.
Saito, I., Miyamura, T., Ohbayashi, A., Harada, H., Katayama, T., Kikuchi, S., Watanabe, Y., Koi, S., Onji, M., & Ohta, Y. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6547 · Cited by 1,089
Gain of function mutations in p53
Dittmer, D., Pati, S., Zambetti, G., Chu, S., Teresky, A. K., Moore, M., Finlay, C., & Levine, A. J. (1993) · Nature Genetics · doi:10.1038/ng0593-42 · Cited by 894
Gale, M. J., Korth, M. J., Tang, N. M., Tan, S.-L., Hopkins, D. A., Dever, T. E., Polyak, S. J., Gretch, D. R., & Katze, M. G. (1997) · Virology · doi:10.1006/viro.1997.8493 · Cited by 810
Twenty years of p53 research: structural and functional aspects of the p53 protein
May, P., & May, E. (1999) · Oncogene · doi:10.1038/sj.onc.1203285 · Cited by 663
Lin, J., Chen, J., Elenbaas, B., & Levine, A. J. (1994) · Genes & Development · doi:10.1101/gad.8.10.1235 · Cited by 653
Enomoto, N., Sakuma, I., Asahina, Y., Kurosaki, M., Murakami, T., Yamamoto, C., Izumi, N., Marumo, F., & Sato, C. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118025 · Cited by 627
Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein
Yew, P. R., & Berk, A. J. (1992) · Nature · doi:10.1038/357082a0 · Cited by 561
Hepatitis C and hepatocellular carcinoma
Di Bisceglie, A. M. (1997) · Hepatology · doi:10.1002/hep.510260706 · Cited by 558
Ray, R. B., Lagging, L. M., Meyer, K., & Ray, R. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4438-4443.1996 · Cited by 403
Self-citationYu, X., Wu, L. C., Bowcock, A. M., Aronheim, A., & Baer, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.25388 · Cited by 389
Abrogation of p53-Induced Apoptosis by the Hepatitis B Virus X Gene
Wang, X. W. (2003) · Hepatocellular Carcinoma · doi:10.1385/1-59259-079-9:57 · Cited by 321
Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells
Sakamuro, D., Furukawa, T., & Takegami, T. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3893-3896.1995 · Cited by 306
Gale, M., Kwieciszewski, B., Dossett, M., Nakao, H., & Katze, M. G. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6506-6516.1999 · Cited by 250
Hepatitis C Virus RNA Polymerase and NS5A Complex with a SNARE-like Protein
Tu, H., Gao, L., Shi, S. T., Taylor, D. R., Yang, T., Mircheff, A. K., Wen, Y., Gorbalenya, A. E., Hwang, S. B., & Lai, M. M. C. (1999) · Virology · doi:10.1006/viro.1999.9893 · Cited by 249
Tan, S.-L., Nakao, H., He, Y., Vijaysri, S., Neddermann, P., Jacobs, B. L., Mayer, B. J., & Katze, M. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5533 · Cited by 233
Nuclear localization is essential for the activity of p53 protein.
Shaulsky, G., Goldfinger, N., Tosky, M. S., Levine, A. J., & Rotter, V. (1991) · PubMed · Cited by 192
Ms, S., Rochefort, H., & Garcia, M. (1995) · PubMed · Cited by 183
Regulation of the interferon-induced PKR: can viruses cope?
Katze, M. G. (1995) · Trends in Microbiology · doi:10.1016/s0966-842x(00)88880-0 · Cited by 174
Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth.
Ghosh, A. K., Steele, R., Meyer, K., Ray, R., & Ray, R. B. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-5-1179 · Cited by 168
Self-citationIdentification of a Novel p53 Functional Domain That Is Necessary for Mediating Apoptosis
Zhu, J., Zhou, W., Jiang, J., & Chen, X. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.13030 · Cited by 166
Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter activity
Ray, R. B., Steele, R., Meyer, K., & Ray, R. (1998) · Gene · doi:10.1016/s0378-1119(98)00030-4 · Cited by 155
Self-citationChang, J., Yang, S.-H., Cho, Y.-G., Hwang, S. B., Hahn, Y. S., & Sung, Y. C. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.3060-3065.1998 · Cited by 136
Binding of p53 to the KIX Domain of CREB Binding Protein
Van Orden, K., Giebler, H. A., Lemasson, I., Gonzales, M., & Nyborg, J. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.37.26321 · Cited by 110
Takada, S., Kaneniwa, N., Tsuchida, N., & Koike, K. (1997) · Oncogene · doi:10.1038/sj.onc.1201369 · Cited by 91
McKenzie, P., Guichard, S. M., Middlemas, D. S., Ashmun, R. A., Danks, M. K., & Harris, L. C. (1999) · PubMed · Cited by 85
Sarrazin, C., Berg, T., Lee, J., Rüster, B., Kronenberger, B., Roth, W. K., & Zeuzem, S. (2000) · The Journal of Infectious Diseases · doi:10.1086/315263 · Cited by 75
Tsai, S.-C., Pasumarthi, K. B. S., Pajak, L., Franklin, M., Patton, B., Wang, H., Henzel, W. J., Stults, J. T., & Field, L. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3239 · Cited by 70
Ghosh, A. K., Steele, R., & Ray, R. B. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2880 · Cited by 63
Self-citationThe Growth-Regulatory Role of p21 (WAF1/CIP1)
Gartel, A. L., & Tyner, A. L. (1998) · Progress in molecular and subcellular biology · doi:10.1007/978-3-642-72149-6_4 · Cited by 57
MBP-1 Physically Associates with Histone Deacetylase for Transcriptional Repression
Ghosh, A. K., Steele, R., & Ray, R. B. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0921 · Cited by 26
Self-citation
Cited by
Hepatocellular carcinoma pathogenesis: from genes to environment
Farazi, P. A., & DePinho, R. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1934 · Cited by 1,979
Molecular pathogenesis of human hepatocellular carcinoma
Thorgeirsson, S. S., & Grisham, J. W. (2002) · Nature Genetics · doi:10.1038/ng0802-339 · Cited by 1,439
Genetic diversity and evolution of hepatitis C virus – 15 years on
Simmonds, P. (2004) · Journal of General Virology · doi:10.1099/vir.0.80401-0 · Cited by 865
Lost in Transcription: p21 Repression, Mechanisms, and Consequences
Gartel, A. L., & Radhakrishnan, S. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3995 · Cited by 818
Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis
Rowe, J., Ghouri, Y., & Mian, I. (2017) · Journal of Carcinogenesis · doi:10.4103/jcar.jcar_9_16 · Cited by 719
Metadata
- Authors
- Majumder, M., Ghosh, A. K., Steele, R., Ray, R., & Ray, R. B.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2001-02
- Volume
- 75
- Issue
- 3
- Pages
- 1401-1407
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2001030705
- Cited by
- 255
- References
- 36
- FWCI
- 13.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.